- Global Kinetics Corporation Ltd Established
Global Kinetics
About Us
Global Kinetics is committed to improving the lives of patients with neurologic conditions using advanced digital health technologies. The company was formed in 2007 to commercialize its lead product, the Personal KinetiGraph (PKG). The PKG System including its proprietary, clinically proven algorithms, enables the precise monitoring, quantification, and reporting of movement disorder symptoms. To date, Global Kinetics has supported clinical research and treatment decisions by healthcare professionals who have treated more than 35,000 patients, generating more than 9,000,000 hours of clinical data from the FDA-cleared, CE-marked, TGA-approved PKG System. Global Kinetics is a privately held company, headquartered in Melbourne, Australia with offices in the United Kingdom and the United States.
Company Overview
Global Kinetics
Global Kinetics, a novel digital health company, is revolutionizing the management of neurological disorders by providing the PKG System which has the largest body of clinical evidence in the world.
The PKG System
History of the PKG system
Initial development of the technology behind the PKG® system began in the late 1990s by Professor Malcolm Horne and Dr Rob Griffiths at the world-renowned Florey Institute of Neuroscience and Mental Health in Melbourne, Australia. The pair worked on developing the data logger, assessment and report creation technology and in 2007, Global Kinetics Corporation (GKC) was established to commercialise this innovative technology.
The PKG® system has evolved to include advanced monitoring technology and reporting capabilities and in 2016 the next generation data logger featuring an interactive touch-screen design – the PKG Watch was launched.
Key milestones for the PKG® system:
- 2007
2007
2007
January 1, 2007 - 2009
2009
2009
January 1, 2009- 1st external funding
- 2011
2011
2011
January 1, 2011- Series 2 capital raise
- Initial product development
- POC clinical studies underway
- 2012
2012
2012
January 8, 2012- TGA Registration
- CE Mark
- 1st product in Australia
- 1st product in Europe
- 1st publication
- 2014
2014
2014
January 1, 2014- Series 3 Capital raise
- 53 Clinical sites
- 1st patent granted
- US Market launch
- 2015
2015
2015
January 1, 2015- Series 4 Capital raise
- US FDA Clearance
- CE Mark 11a
- 1st Reimbursement Sweden
- 2016
2016
2016
January 1, 2016- Series 5 Capital raise
- Second Generation device receives FDA clearance
- 2017
2017
2017
January 1, 2017- +3 million PKG recording hrs
- Second Generation device receives CE mark
- 1st US patent granted
- Fast Company Top 10 in Health
- 2018
2018
2018
January 1, 2018- Series 6 Capital raise
- Roll down: creation of Global Kinetics Pty Ltd and assignment of all asset and liabilities for shares
- 2019
2019
2019
January 1, 2019- Continuous Monitoring product launched
- Clinical Trial Services business launched
- 2020
2020
2020
January 1, 2020- +50 million PKG recording hrs
- 23 peer-reviewed studies
- RPM Pilot
- 2021
2021
2021
September 8, 2021- RPM Launched in the US
- 60,000 PKGs recorded